nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2B6—Citalopram—alcohol dependence	0.146	0.239	CbGbCtD
Efavirenz—CYP2C9—Disulfiram—alcohol dependence	0.108	0.177	CbGbCtD
Efavirenz—CYP2C19—Citalopram—alcohol dependence	0.0927	0.152	CbGbCtD
Efavirenz—CYP1A2—Citalopram—alcohol dependence	0.0855	0.14	CbGbCtD
Efavirenz—CYP2D6—Citalopram—alcohol dependence	0.0704	0.115	CbGbCtD
Efavirenz—CYP3A4—Disulfiram—alcohol dependence	0.0629	0.103	CbGbCtD
Efavirenz—CYP3A4—Citalopram—alcohol dependence	0.0448	0.0734	CbGbCtD
Efavirenz—Eczema—Citalopram—alcohol dependence	0.00054	0.00192	CcSEcCtD
Efavirenz—Hepatic failure—Citalopram—alcohol dependence	0.00054	0.00192	CcSEcCtD
Efavirenz—Visual impairment—Acamprosate—alcohol dependence	0.00054	0.00192	CcSEcCtD
Efavirenz—Dizziness—Disulfiram—alcohol dependence	0.000535	0.0019	CcSEcCtD
Efavirenz—Hepatitis—Naltrexone—alcohol dependence	0.00053	0.00188	CcSEcCtD
Efavirenz—Hallucination—Naltrexone—alcohol dependence	0.000528	0.00187	CcSEcCtD
Efavirenz—Renal failure acute—Citalopram—alcohol dependence	0.000526	0.00187	CcSEcCtD
Efavirenz—Tinnitus—Acamprosate—alcohol dependence	0.000523	0.00185	CcSEcCtD
Efavirenz—Connective tissue disorder—Naltrexone—alcohol dependence	0.000521	0.00185	CcSEcCtD
Efavirenz—Hot flush—Citalopram—alcohol dependence	0.000519	0.00184	CcSEcCtD
Efavirenz—Amnesia—Citalopram—alcohol dependence	0.000517	0.00183	CcSEcCtD
Efavirenz—Menopausal symptoms—Citalopram—alcohol dependence	0.000515	0.00183	CcSEcCtD
Efavirenz—Rash—Disulfiram—alcohol dependence	0.00051	0.00181	CcSEcCtD
Efavirenz—Dermatitis bullous—Citalopram—alcohol dependence	0.000508	0.0018	CcSEcCtD
Efavirenz—Headache—Disulfiram—alcohol dependence	0.000506	0.0018	CcSEcCtD
Efavirenz—Immune system disorder—Acamprosate—alcohol dependence	0.000506	0.0018	CcSEcCtD
Efavirenz—Eye disorder—Naltrexone—alcohol dependence	0.000496	0.00176	CcSEcCtD
Efavirenz—Alopecia—Acamprosate—alcohol dependence	0.000495	0.00176	CcSEcCtD
Efavirenz—Tinnitus—Naltrexone—alcohol dependence	0.000494	0.00175	CcSEcCtD
Efavirenz—Cardiac disorder—Naltrexone—alcohol dependence	0.000492	0.00175	CcSEcCtD
Efavirenz—Malnutrition—Acamprosate—alcohol dependence	0.000488	0.00173	CcSEcCtD
Efavirenz—Diplopia—Citalopram—alcohol dependence	0.000486	0.00172	CcSEcCtD
Efavirenz—Angiopathy—Naltrexone—alcohol dependence	0.000481	0.00171	CcSEcCtD
Efavirenz—Flatulence—Acamprosate—alcohol dependence	0.000481	0.00171	CcSEcCtD
Efavirenz—Immune system disorder—Naltrexone—alcohol dependence	0.000479	0.0017	CcSEcCtD
Efavirenz—Tension—Acamprosate—alcohol dependence	0.000479	0.0017	CcSEcCtD
Efavirenz—Affect lability—Citalopram—alcohol dependence	0.000478	0.0017	CcSEcCtD
Efavirenz—Migraine—Citalopram—alcohol dependence	0.000478	0.0017	CcSEcCtD
Efavirenz—Mediastinal disorder—Naltrexone—alcohol dependence	0.000478	0.00169	CcSEcCtD
Efavirenz—Dysgeusia—Acamprosate—alcohol dependence	0.000478	0.00169	CcSEcCtD
Efavirenz—Psychotic disorder—Citalopram—alcohol dependence	0.000474	0.00168	CcSEcCtD
Efavirenz—Nervousness—Acamprosate—alcohol dependence	0.000474	0.00168	CcSEcCtD
Efavirenz—Back pain—Acamprosate—alcohol dependence	0.000472	0.00167	CcSEcCtD
Efavirenz—Alopecia—Naltrexone—alcohol dependence	0.000469	0.00166	CcSEcCtD
Efavirenz—Malnutrition—Naltrexone—alcohol dependence	0.000462	0.00164	CcSEcCtD
Efavirenz—Mood swings—Citalopram—alcohol dependence	0.00046	0.00163	CcSEcCtD
Efavirenz—Tremor—Acamprosate—alcohol dependence	0.000457	0.00162	CcSEcCtD
Efavirenz—Ataxia—Citalopram—alcohol dependence	0.000457	0.00162	CcSEcCtD
Efavirenz—Flatulence—Naltrexone—alcohol dependence	0.000455	0.00161	CcSEcCtD
Efavirenz—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000455	0.00424	CbGpPWpGaD
Efavirenz—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000454	0.00423	CbGpPWpGaD
Efavirenz—Tension—Naltrexone—alcohol dependence	0.000453	0.00161	CcSEcCtD
Efavirenz—Ill-defined disorder—Acamprosate—alcohol dependence	0.000453	0.00161	CcSEcCtD
Efavirenz—Dysgeusia—Naltrexone—alcohol dependence	0.000452	0.0016	CcSEcCtD
Efavirenz—Anaemia—Acamprosate—alcohol dependence	0.000451	0.0016	CcSEcCtD
Efavirenz—Agitation—Acamprosate—alcohol dependence	0.000448	0.00159	CcSEcCtD
Efavirenz—Nervousness—Naltrexone—alcohol dependence	0.000448	0.00159	CcSEcCtD
Efavirenz—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.000448	0.00418	CbGpPWpGaD
Efavirenz—Back pain—Naltrexone—alcohol dependence	0.000447	0.00158	CcSEcCtD
Efavirenz—Angioedema—Acamprosate—alcohol dependence	0.000446	0.00158	CcSEcCtD
Efavirenz—Hypokalaemia—Citalopram—alcohol dependence	0.000442	0.00157	CcSEcCtD
Efavirenz—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00044	0.0041	CbGpPWpGaD
Efavirenz—Malaise—Acamprosate—alcohol dependence	0.00044	0.00156	CcSEcCtD
Efavirenz—Breast disorder—Citalopram—alcohol dependence	0.000439	0.00156	CcSEcCtD
Efavirenz—Vertigo—Acamprosate—alcohol dependence	0.000438	0.00155	CcSEcCtD
Efavirenz—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000438	0.00408	CbGpPWpGaD
Efavirenz—Syncope—Acamprosate—alcohol dependence	0.000438	0.00155	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000437	0.00155	CcSEcCtD
Efavirenz—Vision blurred—Naltrexone—alcohol dependence	0.000435	0.00154	CcSEcCtD
Efavirenz—Nasopharyngitis—Citalopram—alcohol dependence	0.000434	0.00154	CcSEcCtD
Efavirenz—Tremor—Naltrexone—alcohol dependence	0.000433	0.00153	CcSEcCtD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000431	0.00402	CbGpPWpGaD
Efavirenz—Palpitations—Acamprosate—alcohol dependence	0.000431	0.00153	CcSEcCtD
Efavirenz—Loss of consciousness—Acamprosate—alcohol dependence	0.000429	0.00152	CcSEcCtD
Efavirenz—CYP2B6—Biological oxidations—ADH4—alcohol dependence	0.000429	0.004	CbGpPWpGaD
Efavirenz—Muscular weakness—Citalopram—alcohol dependence	0.000428	0.00152	CcSEcCtD
Efavirenz—Ill-defined disorder—Naltrexone—alcohol dependence	0.000428	0.00152	CcSEcCtD
Efavirenz—CYP2D6—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000428	0.00399	CbGpPWpGaD
Efavirenz—Cough—Acamprosate—alcohol dependence	0.000426	0.00151	CcSEcCtD
Efavirenz—Agitation—Naltrexone—alcohol dependence	0.000424	0.0015	CcSEcCtD
Efavirenz—CYP2B6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000424	0.00395	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—ADH6—alcohol dependence	0.000423	0.00394	CbGpPWpGaD
Efavirenz—Convulsion—Acamprosate—alcohol dependence	0.000423	0.0015	CcSEcCtD
Efavirenz—Abdominal distension—Citalopram—alcohol dependence	0.000423	0.0015	CcSEcCtD
Efavirenz—Angioedema—Naltrexone—alcohol dependence	0.000422	0.0015	CcSEcCtD
Efavirenz—Hypertension—Acamprosate—alcohol dependence	0.000421	0.00149	CcSEcCtD
Efavirenz—Asthma—Citalopram—alcohol dependence	0.00042	0.00149	CcSEcCtD
Efavirenz—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000419	0.00391	CbGpPWpGaD
Efavirenz—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000418	0.0039	CbGpPWpGaD
Efavirenz—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000418	0.0039	CbGpPWpGaD
Efavirenz—Malaise—Naltrexone—alcohol dependence	0.000416	0.00148	CcSEcCtD
Efavirenz—Arthralgia—Acamprosate—alcohol dependence	0.000415	0.00147	CcSEcCtD
Efavirenz—Chest pain—Acamprosate—alcohol dependence	0.000415	0.00147	CcSEcCtD
Efavirenz—Myalgia—Acamprosate—alcohol dependence	0.000415	0.00147	CcSEcCtD
Efavirenz—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000415	0.00387	CbGpPWpGaD
Efavirenz—Syncope—Naltrexone—alcohol dependence	0.000414	0.00147	CcSEcCtD
Efavirenz—Anxiety—Acamprosate—alcohol dependence	0.000414	0.00147	CcSEcCtD
Efavirenz—CYP2B6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000413	0.00385	CbGpPWpGaD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000413	0.00146	CcSEcCtD
Efavirenz—Pancreatitis—Citalopram—alcohol dependence	0.000412	0.00146	CcSEcCtD
Efavirenz—Discomfort—Acamprosate—alcohol dependence	0.00041	0.00146	CcSEcCtD
Efavirenz—Sweating increased—Citalopram—alcohol dependence	0.000409	0.00145	CcSEcCtD
Efavirenz—Palpitations—Naltrexone—alcohol dependence	0.000408	0.00145	CcSEcCtD
Efavirenz—Dry mouth—Acamprosate—alcohol dependence	0.000406	0.00144	CcSEcCtD
Efavirenz—Loss of consciousness—Naltrexone—alcohol dependence	0.000406	0.00144	CcSEcCtD
Efavirenz—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000404	0.00377	CbGpPWpGaD
Efavirenz—Cough—Naltrexone—alcohol dependence	0.000403	0.00143	CcSEcCtD
Efavirenz—Confusional state—Acamprosate—alcohol dependence	0.000402	0.00142	CcSEcCtD
Efavirenz—Convulsion—Naltrexone—alcohol dependence	0.0004	0.00142	CcSEcCtD
Efavirenz—Pancytopenia—Citalopram—alcohol dependence	0.000399	0.00141	CcSEcCtD
Efavirenz—Hypertension—Naltrexone—alcohol dependence	0.000399	0.00141	CcSEcCtD
Efavirenz—Arthralgia—Naltrexone—alcohol dependence	0.000393	0.00139	CcSEcCtD
Efavirenz—Myalgia—Naltrexone—alcohol dependence	0.000393	0.00139	CcSEcCtD
Efavirenz—Chest pain—Naltrexone—alcohol dependence	0.000393	0.00139	CcSEcCtD
Efavirenz—Shock—Acamprosate—alcohol dependence	0.000392	0.00139	CcSEcCtD
Efavirenz—Anxiety—Naltrexone—alcohol dependence	0.000392	0.00139	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00039	0.00138	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00039	0.00138	CcSEcCtD
Efavirenz—Thrombocytopenia—Acamprosate—alcohol dependence	0.00039	0.00138	CcSEcCtD
Efavirenz—Tachycardia—Acamprosate—alcohol dependence	0.000389	0.00138	CcSEcCtD
Efavirenz—Discomfort—Naltrexone—alcohol dependence	0.000388	0.00138	CcSEcCtD
Efavirenz—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000388	0.00362	CbGpPWpGaD
Efavirenz—Skin disorder—Acamprosate—alcohol dependence	0.000387	0.00137	CcSEcCtD
Efavirenz—Hyperhidrosis—Acamprosate—alcohol dependence	0.000385	0.00137	CcSEcCtD
Efavirenz—Dry mouth—Naltrexone—alcohol dependence	0.000384	0.00136	CcSEcCtD
Efavirenz—Photosensitivity reaction—Citalopram—alcohol dependence	0.000383	0.00136	CcSEcCtD
Efavirenz—CYP2C19—Biological oxidations—ADH1A—alcohol dependence	0.000381	0.00355	CbGpPWpGaD
Efavirenz—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000381	0.00355	CbGpPWpGaD
Efavirenz—Confusional state—Naltrexone—alcohol dependence	0.00038	0.00135	CcSEcCtD
Efavirenz—Anorexia—Acamprosate—alcohol dependence	0.00038	0.00135	CcSEcCtD
Efavirenz—Hyperglycaemia—Citalopram—alcohol dependence	0.000379	0.00134	CcSEcCtD
Efavirenz—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000377	0.00351	CbGpPWpGaD
Efavirenz—Pneumonia—Citalopram—alcohol dependence	0.000376	0.00134	CcSEcCtD
Efavirenz—Infestation NOS—Citalopram—alcohol dependence	0.000374	0.00133	CcSEcCtD
Efavirenz—Infestation—Citalopram—alcohol dependence	0.000374	0.00133	CcSEcCtD
Efavirenz—Depression—Citalopram—alcohol dependence	0.000373	0.00132	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000371	0.00132	CcSEcCtD
Efavirenz—Shock—Naltrexone—alcohol dependence	0.000371	0.00131	CcSEcCtD
Efavirenz—Nervous system disorder—Naltrexone—alcohol dependence	0.000369	0.00131	CcSEcCtD
Efavirenz—Tachycardia—Naltrexone—alcohol dependence	0.000368	0.0013	CcSEcCtD
Efavirenz—Neuropathy peripheral—Citalopram—alcohol dependence	0.000367	0.0013	CcSEcCtD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000367	0.00342	CbGpPWpGaD
Efavirenz—Skin disorder—Naltrexone—alcohol dependence	0.000366	0.0013	CcSEcCtD
Efavirenz—Jaundice—Citalopram—alcohol dependence	0.000365	0.00129	CcSEcCtD
Efavirenz—CYP2B6—Biological oxidations—ADH7—alcohol dependence	0.000365	0.0034	CbGpPWpGaD
Efavirenz—Hyperhidrosis—Naltrexone—alcohol dependence	0.000364	0.00129	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000363	0.00129	CcSEcCtD
Efavirenz—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000362	0.00338	CbGpPWpGaD
Efavirenz—Insomnia—Acamprosate—alcohol dependence	0.00036	0.00128	CcSEcCtD
Efavirenz—Anorexia—Naltrexone—alcohol dependence	0.000359	0.00127	CcSEcCtD
Efavirenz—Sweating—Citalopram—alcohol dependence	0.000359	0.00127	CcSEcCtD
Efavirenz—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.000358	0.00334	CbGpPWpGaD
Efavirenz—Paraesthesia—Acamprosate—alcohol dependence	0.000358	0.00127	CcSEcCtD
Efavirenz—Haematuria—Citalopram—alcohol dependence	0.000357	0.00127	CcSEcCtD
Efavirenz—Dyspnoea—Acamprosate—alcohol dependence	0.000355	0.00126	CcSEcCtD
Efavirenz—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000354	0.0033	CbGpPWpGaD
Efavirenz—Somnolence—Acamprosate—alcohol dependence	0.000354	0.00126	CcSEcCtD
Efavirenz—Hepatobiliary disease—Citalopram—alcohol dependence	0.000354	0.00126	CcSEcCtD
Efavirenz—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.000352	0.00328	CbGpPWpGaD
Efavirenz—Sinusitis—Citalopram—alcohol dependence	0.000351	0.00125	CcSEcCtD
Efavirenz—Dyspepsia—Acamprosate—alcohol dependence	0.000351	0.00124	CcSEcCtD
Efavirenz—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.00035	0.00327	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—GGT2—alcohol dependence	0.00035	0.00326	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000347	0.00324	CbGpPWpGaD
Efavirenz—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000347	0.00323	CbGpPWpGaD
Efavirenz—Decreased appetite—Acamprosate—alcohol dependence	0.000346	0.00123	CcSEcCtD
Efavirenz—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000346	0.00322	CbGpPWpGaD
Efavirenz—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000344	0.00122	CcSEcCtD
Efavirenz—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000344	0.0032	CbGpPWpGaD
Efavirenz—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000343	0.00122	CcSEcCtD
Efavirenz—Insomnia—Naltrexone—alcohol dependence	0.000341	0.00121	CcSEcCtD
Efavirenz—Constipation—Acamprosate—alcohol dependence	0.000341	0.00121	CcSEcCtD
Efavirenz—Pain—Acamprosate—alcohol dependence	0.000341	0.00121	CcSEcCtD
Efavirenz—CYP2B6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000339	0.00316	CbGpPWpGaD
Efavirenz—Paraesthesia—Naltrexone—alcohol dependence	0.000338	0.0012	CcSEcCtD
Efavirenz—Rhinitis—Citalopram—alcohol dependence	0.000337	0.00119	CcSEcCtD
Efavirenz—Hepatitis—Citalopram—alcohol dependence	0.000336	0.00119	CcSEcCtD
Efavirenz—Dyspnoea—Naltrexone—alcohol dependence	0.000336	0.00119	CcSEcCtD
Efavirenz—CYP2C19—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000336	0.00313	CbGpPWpGaD
Efavirenz—Somnolence—Naltrexone—alcohol dependence	0.000335	0.00119	CcSEcCtD
Efavirenz—Hallucination—Citalopram—alcohol dependence	0.000334	0.00119	CcSEcCtD
Efavirenz—Hypoaesthesia—Citalopram—alcohol dependence	0.000334	0.00119	CcSEcCtD
Efavirenz—Urinary tract disorder—Citalopram—alcohol dependence	0.000332	0.00118	CcSEcCtD
Efavirenz—Oedema peripheral—Citalopram—alcohol dependence	0.000331	0.00117	CcSEcCtD
Efavirenz—Connective tissue disorder—Citalopram—alcohol dependence	0.00033	0.00117	CcSEcCtD
Efavirenz—Urethral disorder—Citalopram—alcohol dependence	0.000329	0.00117	CcSEcCtD
Efavirenz—Feeling abnormal—Acamprosate—alcohol dependence	0.000328	0.00116	CcSEcCtD
Efavirenz—Decreased appetite—Naltrexone—alcohol dependence	0.000328	0.00116	CcSEcCtD
Efavirenz—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000326	0.00115	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000325	0.00115	CcSEcCtD
Efavirenz—Fatigue—Naltrexone—alcohol dependence	0.000325	0.00115	CcSEcCtD
Efavirenz—CYP2C19—Biological oxidations—ADH4—alcohol dependence	0.000324	0.00302	CbGpPWpGaD
Efavirenz—Visual impairment—Citalopram—alcohol dependence	0.000324	0.00115	CcSEcCtD
Efavirenz—Pain—Naltrexone—alcohol dependence	0.000322	0.00114	CcSEcCtD
Efavirenz—Constipation—Naltrexone—alcohol dependence	0.000322	0.00114	CcSEcCtD
Efavirenz—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00032	0.00299	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—ADH1B—alcohol dependence	0.00032	0.00298	CbGpPWpGaD
Efavirenz—Erythema multiforme—Citalopram—alcohol dependence	0.000318	0.00113	CcSEcCtD
Efavirenz—Urticaria—Acamprosate—alcohol dependence	0.000316	0.00112	CcSEcCtD
Efavirenz—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000316	0.00295	CbGpPWpGaD
Efavirenz—Body temperature increased—Acamprosate—alcohol dependence	0.000315	0.00112	CcSEcCtD
Efavirenz—Abdominal pain—Acamprosate—alcohol dependence	0.000315	0.00112	CcSEcCtD
Efavirenz—Eye disorder—Citalopram—alcohol dependence	0.000314	0.00111	CcSEcCtD
Efavirenz—Tinnitus—Citalopram—alcohol dependence	0.000313	0.00111	CcSEcCtD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000312	0.00291	CbGpPWpGaD
Efavirenz—Flushing—Citalopram—alcohol dependence	0.000312	0.00111	CcSEcCtD
Efavirenz—Cardiac disorder—Citalopram—alcohol dependence	0.000312	0.00111	CcSEcCtD
Efavirenz—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000312	0.00291	CbGpPWpGaD
Efavirenz—Feeling abnormal—Naltrexone—alcohol dependence	0.00031	0.0011	CcSEcCtD
Efavirenz—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000308	0.00109	CcSEcCtD
Efavirenz—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000306	0.00285	CbGpPWpGaD
Efavirenz—Angiopathy—Citalopram—alcohol dependence	0.000305	0.00108	CcSEcCtD
Efavirenz—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000304	0.00284	CbGpPWpGaD
Efavirenz—Immune system disorder—Citalopram—alcohol dependence	0.000304	0.00108	CcSEcCtD
Efavirenz—Mediastinal disorder—Citalopram—alcohol dependence	0.000303	0.00107	CcSEcCtD
Efavirenz—Arrhythmia—Citalopram—alcohol dependence	0.0003	0.00106	CcSEcCtD
Efavirenz—Urticaria—Naltrexone—alcohol dependence	0.000299	0.00106	CcSEcCtD
Efavirenz—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000299	0.00279	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.000298	0.00278	CbGpPWpGaD
Efavirenz—Body temperature increased—Naltrexone—alcohol dependence	0.000298	0.00106	CcSEcCtD
Efavirenz—Abdominal pain—Naltrexone—alcohol dependence	0.000298	0.00106	CcSEcCtD
Efavirenz—Alopecia—Citalopram—alcohol dependence	0.000297	0.00105	CcSEcCtD
Efavirenz—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.000297	0.00277	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000295	0.00276	CbGpPWpGaD
Efavirenz—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000295	0.00275	CbGpPWpGaD
Efavirenz—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000294	0.00274	CbGpPWpGaD
Efavirenz—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000294	0.00274	CbGpPWpGaD
Efavirenz—Hypersensitivity—Acamprosate—alcohol dependence	0.000293	0.00104	CcSEcCtD
Efavirenz—Erythema—Citalopram—alcohol dependence	0.000293	0.00104	CcSEcCtD
Efavirenz—Malnutrition—Citalopram—alcohol dependence	0.000293	0.00104	CcSEcCtD
Efavirenz—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000292	0.00272	CbGpPWpGaD
Efavirenz—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000291	0.00271	CbGpPWpGaD
Efavirenz—Flatulence—Citalopram—alcohol dependence	0.000288	0.00102	CcSEcCtD
Efavirenz—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000288	0.00269	CbGpPWpGaD
Efavirenz—Tension—Citalopram—alcohol dependence	0.000287	0.00102	CcSEcCtD
Efavirenz—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000287	0.00267	CbGpPWpGaD
Efavirenz—Dysgeusia—Citalopram—alcohol dependence	0.000286	0.00102	CcSEcCtD
Efavirenz—Asthenia—Acamprosate—alcohol dependence	0.000286	0.00101	CcSEcCtD
Efavirenz—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000284	0.00265	CbGpPWpGaD
Efavirenz—Nervousness—Citalopram—alcohol dependence	0.000284	0.00101	CcSEcCtD
Efavirenz—Back pain—Citalopram—alcohol dependence	0.000283	0.001	CcSEcCtD
Efavirenz—Pruritus—Acamprosate—alcohol dependence	0.000282	0.000999	CcSEcCtD
Efavirenz—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000279	0.0026	CbGpPWpGaD
Efavirenz—Hypersensitivity—Naltrexone—alcohol dependence	0.000278	0.000984	CcSEcCtD
Efavirenz—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000277	0.00258	CbGpPWpGaD
Efavirenz—Vision blurred—Citalopram—alcohol dependence	0.000276	0.000978	CcSEcCtD
Efavirenz—CYP2C19—Biological oxidations—ADH7—alcohol dependence	0.000275	0.00257	CbGpPWpGaD
Efavirenz—Tremor—Citalopram—alcohol dependence	0.000274	0.000972	CcSEcCtD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000273	0.00255	CbGpPWpGaD
Efavirenz—Diarrhoea—Acamprosate—alcohol dependence	0.000272	0.000966	CcSEcCtD
Efavirenz—Ill-defined disorder—Citalopram—alcohol dependence	0.000271	0.000962	CcSEcCtD
Efavirenz—Anaemia—Citalopram—alcohol dependence	0.00027	0.000959	CcSEcCtD
Efavirenz—Asthenia—Naltrexone—alcohol dependence	0.00027	0.000959	CcSEcCtD
Efavirenz—Agitation—Citalopram—alcohol dependence	0.000269	0.000953	CcSEcCtD
Efavirenz—Angioedema—Citalopram—alcohol dependence	0.000267	0.000948	CcSEcCtD
Efavirenz—Pruritus—Naltrexone—alcohol dependence	0.000267	0.000945	CcSEcCtD
Efavirenz—CYP2B6—Biological oxidations—MAOB—alcohol dependence	0.000265	0.00247	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—GGT2—alcohol dependence	0.000264	0.00246	CbGpPWpGaD
Efavirenz—Malaise—Citalopram—alcohol dependence	0.000264	0.000935	CcSEcCtD
Efavirenz—Dizziness—Acamprosate—alcohol dependence	0.000263	0.000934	CcSEcCtD
Efavirenz—Vertigo—Citalopram—alcohol dependence	0.000263	0.000932	CcSEcCtD
Efavirenz—Syncope—Citalopram—alcohol dependence	0.000262	0.00093	CcSEcCtD
Efavirenz—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000262	0.00244	CbGpPWpGaD
Efavirenz—Palpitations—Citalopram—alcohol dependence	0.000258	0.000917	CcSEcCtD
Efavirenz—Diarrhoea—Naltrexone—alcohol dependence	0.000258	0.000914	CcSEcCtD
Efavirenz—Loss of consciousness—Citalopram—alcohol dependence	0.000257	0.000912	CcSEcCtD
Efavirenz—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000256	0.00239	CbGpPWpGaD
Efavirenz—Cough—Citalopram—alcohol dependence	0.000255	0.000905	CcSEcCtD
Efavirenz—Convulsion—Citalopram—alcohol dependence	0.000253	0.000899	CcSEcCtD
Efavirenz—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.000253	0.00236	CbGpPWpGaD
Efavirenz—Vomiting—Acamprosate—alcohol dependence	0.000253	0.000898	CcSEcCtD
Efavirenz—Hypertension—Citalopram—alcohol dependence	0.000253	0.000896	CcSEcCtD
Efavirenz—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.000252	0.00235	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000251	0.00234	CbGpPWpGaD
Efavirenz—Rash—Acamprosate—alcohol dependence	0.000251	0.00089	CcSEcCtD
Efavirenz—Dermatitis—Acamprosate—alcohol dependence	0.000251	0.00089	CcSEcCtD
Efavirenz—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00025	0.00233	CbGpPWpGaD
Efavirenz—Headache—Acamprosate—alcohol dependence	0.000249	0.000885	CcSEcCtD
Efavirenz—Dizziness—Naltrexone—alcohol dependence	0.000249	0.000884	CcSEcCtD
Efavirenz—Arthralgia—Citalopram—alcohol dependence	0.000249	0.000883	CcSEcCtD
Efavirenz—Chest pain—Citalopram—alcohol dependence	0.000249	0.000883	CcSEcCtD
Efavirenz—Myalgia—Citalopram—alcohol dependence	0.000249	0.000883	CcSEcCtD
Efavirenz—Anxiety—Citalopram—alcohol dependence	0.000248	0.00088	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000247	0.000877	CcSEcCtD
Efavirenz—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000246	0.0023	CbGpPWpGaD
Efavirenz—Discomfort—Citalopram—alcohol dependence	0.000246	0.000873	CcSEcCtD
Efavirenz—Dry mouth—Citalopram—alcohol dependence	0.000244	0.000864	CcSEcCtD
Efavirenz—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000243	0.00227	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000243	0.00227	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—ADH1B—alcohol dependence	0.000242	0.00225	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000241	0.00225	CbGpPWpGaD
Efavirenz—Confusional state—Citalopram—alcohol dependence	0.000241	0.000854	CcSEcCtD
Efavirenz—Vomiting—Naltrexone—alcohol dependence	0.00024	0.00085	CcSEcCtD
Efavirenz—Rash—Naltrexone—alcohol dependence	0.000238	0.000842	CcSEcCtD
Efavirenz—Dermatitis—Naltrexone—alcohol dependence	0.000237	0.000842	CcSEcCtD
Efavirenz—Nausea—Acamprosate—alcohol dependence	0.000237	0.000839	CcSEcCtD
Efavirenz—Headache—Naltrexone—alcohol dependence	0.000236	0.000837	CcSEcCtD
Efavirenz—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000236	0.0022	CbGpPWpGaD
Efavirenz—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000235	0.00219	CbGpPWpGaD
Efavirenz—Shock—Citalopram—alcohol dependence	0.000235	0.000833	CcSEcCtD
Efavirenz—Nervous system disorder—Citalopram—alcohol dependence	0.000234	0.00083	CcSEcCtD
Efavirenz—Thrombocytopenia—Citalopram—alcohol dependence	0.000234	0.000829	CcSEcCtD
Efavirenz—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000234	0.00218	CbGpPWpGaD
Efavirenz—Tachycardia—Citalopram—alcohol dependence	0.000233	0.000826	CcSEcCtD
Efavirenz—Skin disorder—Citalopram—alcohol dependence	0.000232	0.000822	CcSEcCtD
Efavirenz—Hyperhidrosis—Citalopram—alcohol dependence	0.000231	0.000818	CcSEcCtD
Efavirenz—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000229	0.00214	CbGpPWpGaD
Efavirenz—Anorexia—Citalopram—alcohol dependence	0.000228	0.000807	CcSEcCtD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000227	0.00211	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—ALDH2—alcohol dependence	0.000225	0.0021	CbGpPWpGaD
Efavirenz—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000224	0.00209	CbGpPWpGaD
Efavirenz—Nausea—Naltrexone—alcohol dependence	0.000224	0.000794	CcSEcCtD
Efavirenz—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000222	0.00207	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.00022	0.00205	CbGpPWpGaD
Efavirenz—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000217	0.000771	CcSEcCtD
Efavirenz—Insomnia—Citalopram—alcohol dependence	0.000216	0.000766	CcSEcCtD
Efavirenz—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000215	0.002	CbGpPWpGaD
Efavirenz—Paraesthesia—Citalopram—alcohol dependence	0.000214	0.00076	CcSEcCtD
Efavirenz—Dyspnoea—Citalopram—alcohol dependence	0.000213	0.000755	CcSEcCtD
Efavirenz—Somnolence—Citalopram—alcohol dependence	0.000212	0.000753	CcSEcCtD
Efavirenz—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000211	0.00197	CbGpPWpGaD
Efavirenz—Dyspepsia—Citalopram—alcohol dependence	0.00021	0.000745	CcSEcCtD
Efavirenz—Decreased appetite—Citalopram—alcohol dependence	0.000208	0.000736	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000206	0.000731	CcSEcCtD
Efavirenz—Fatigue—Citalopram—alcohol dependence	0.000206	0.00073	CcSEcCtD
Efavirenz—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.000206	0.00192	CbGpPWpGaD
Efavirenz—Pain—Citalopram—alcohol dependence	0.000204	0.000724	CcSEcCtD
Efavirenz—Constipation—Citalopram—alcohol dependence	0.000204	0.000724	CcSEcCtD
Efavirenz—CYP2C19—Biological oxidations—MAOB—alcohol dependence	0.0002	0.00187	CbGpPWpGaD
Efavirenz—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.0002	0.00186	CbGpPWpGaD
Efavirenz—Feeling abnormal—Citalopram—alcohol dependence	0.000197	0.000698	CcSEcCtD
Efavirenz—Gastrointestinal pain—Citalopram—alcohol dependence	0.000195	0.000692	CcSEcCtD
Efavirenz—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000195	0.00182	CbGpPWpGaD
Efavirenz—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000194	0.00181	CbGpPWpGaD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000193	0.0018	CbGpPWpGaD
Efavirenz—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000192	0.00179	CbGpPWpGaD
Efavirenz—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00019	0.00177	CbGpPWpGaD
Efavirenz—Urticaria—Citalopram—alcohol dependence	0.00019	0.000673	CcSEcCtD
Efavirenz—Body temperature increased—Citalopram—alcohol dependence	0.000189	0.000669	CcSEcCtD
Efavirenz—Abdominal pain—Citalopram—alcohol dependence	0.000189	0.000669	CcSEcCtD
Efavirenz—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000188	0.00176	CbGpPWpGaD
Efavirenz—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000188	0.00175	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.000184	0.00172	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000183	0.0017	CbGpPWpGaD
Efavirenz—CYP2B6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000182	0.00169	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—CYP2E1—alcohol dependence	0.00018	0.00168	CbGpPWpGaD
Efavirenz—CYP2B6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000178	0.00166	CbGpPWpGaD
Efavirenz—Hypersensitivity—Citalopram—alcohol dependence	0.000176	0.000624	CcSEcCtD
Efavirenz—Asthenia—Citalopram—alcohol dependence	0.000171	0.000607	CcSEcCtD
Efavirenz—CYP2C19—Biological oxidations—ALDH2—alcohol dependence	0.00017	0.00159	CbGpPWpGaD
Efavirenz—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000169	0.00158	CbGpPWpGaD
Efavirenz—Pruritus—Citalopram—alcohol dependence	0.000169	0.000599	CcSEcCtD
Efavirenz—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000166	0.00155	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000166	0.00154	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—GGT1—alcohol dependence	0.000165	0.00154	CbGpPWpGaD
Efavirenz—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000164	0.00153	CbGpPWpGaD
Efavirenz—Diarrhoea—Citalopram—alcohol dependence	0.000163	0.000579	CcSEcCtD
Efavirenz—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000159	0.00148	CbGpPWpGaD
Efavirenz—Dizziness—Citalopram—alcohol dependence	0.000158	0.00056	CcSEcCtD
Efavirenz—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.000157	0.00146	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000156	0.00145	CbGpPWpGaD
Efavirenz—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000156	0.00145	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000155	0.00145	CbGpPWpGaD
Efavirenz—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000154	0.00144	CbGpPWpGaD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000154	0.00144	CbGpPWpGaD
Efavirenz—Vomiting—Citalopram—alcohol dependence	0.000152	0.000538	CcSEcCtD
Efavirenz—Rash—Citalopram—alcohol dependence	0.000151	0.000534	CcSEcCtD
Efavirenz—Dermatitis—Citalopram—alcohol dependence	0.00015	0.000533	CcSEcCtD
Efavirenz—Headache—Citalopram—alcohol dependence	0.00015	0.00053	CcSEcCtD
Efavirenz—CYP2B6—Biological oxidations—MAOA—alcohol dependence	0.000148	0.00138	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000145	0.00135	CbGpPWpGaD
Efavirenz—Nausea—Citalopram—alcohol dependence	0.000142	0.000503	CcSEcCtD
Efavirenz—CYP2C19—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000137	0.00128	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—CYP2E1—alcohol dependence	0.000136	0.00127	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000134	0.00125	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.000133	0.00124	CbGpPWpGaD
Efavirenz—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000132	0.00123	CbGpPWpGaD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000127	0.00118	CbGpPWpGaD
Efavirenz—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000126	0.00118	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000125	0.00117	CbGpPWpGaD
Efavirenz—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000125	0.00117	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—GGT1—alcohol dependence	0.000125	0.00116	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000124	0.00116	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000123	0.00115	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000122	0.00114	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.00012	0.00112	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—GGT1—alcohol dependence	0.000115	0.00107	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000114	0.00106	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—MAOA—alcohol dependence	0.000112	0.00104	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000108	0.00101	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000108	0.00101	CbGpPWpGaD
Efavirenz—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000107	0.000997	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.000106	0.000989	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000105	0.000975	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ADH6—alcohol dependence	0.000104	0.000971	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—MAOA—alcohol dependence	0.000103	0.00096	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000102	0.000954	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000102	0.000952	CbGpPWpGaD
Efavirenz—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000102	0.000949	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—GGT1—alcohol dependence	9.73e-05	0.000908	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—POMC—alcohol dependence	9.64e-05	0.000899	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—MAOA—alcohol dependence	8.72e-05	0.000813	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ADH1A—alcohol dependence	8.62e-05	0.000804	CbGpPWpGaD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	8.25e-05	0.000769	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	8.18e-05	0.000763	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	8.07e-05	0.000753	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADH6—alcohol dependence	7.86e-05	0.000733	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GGT1—alcohol dependence	7.51e-05	0.000701	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ADH4—alcohol dependence	7.33e-05	0.000684	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—POMC—alcohol dependence	7.29e-05	0.00068	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADH6—alcohol dependence	7.23e-05	0.000675	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADH6—alcohol dependence	7.17e-05	0.000669	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—MAOA—alcohol dependence	6.73e-05	0.000628	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—POMC—alcohol dependence	6.7e-05	0.000625	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—POMC—alcohol dependence	6.65e-05	0.00062	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADH1A—alcohol dependence	6.52e-05	0.000608	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ADH7—alcohol dependence	6.23e-05	0.000581	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADH6—alcohol dependence	6.13e-05	0.000571	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADH1A—alcohol dependence	5.99e-05	0.000559	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GGT2—alcohol dependence	5.98e-05	0.000557	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADH1A—alcohol dependence	5.94e-05	0.000554	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—POMC—alcohol dependence	5.68e-05	0.00053	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADH4—alcohol dependence	5.54e-05	0.000517	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ADH1B—alcohol dependence	5.47e-05	0.00051	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADH4—alcohol dependence	5.1e-05	0.000475	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADH1A—alcohol dependence	5.08e-05	0.000474	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADH4—alcohol dependence	5.05e-05	0.000471	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	4.8e-05	0.000447	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADH6—alcohol dependence	4.73e-05	0.000441	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADH7—alcohol dependence	4.71e-05	0.000439	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MAOB—alcohol dependence	4.53e-05	0.000422	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GGT2—alcohol dependence	4.52e-05	0.000421	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—POMC—alcohol dependence	4.38e-05	0.000409	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	4.37e-05	0.000408	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADH7—alcohol dependence	4.33e-05	0.000404	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADH4—alcohol dependence	4.32e-05	0.000403	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADH7—alcohol dependence	4.3e-05	0.000401	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GGT2—alcohol dependence	4.15e-05	0.000387	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADH1B—alcohol dependence	4.13e-05	0.000385	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GGT2—alcohol dependence	4.12e-05	0.000384	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADH1A—alcohol dependence	3.92e-05	0.000365	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALDH2—alcohol dependence	3.85e-05	0.000359	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADH1B—alcohol dependence	3.8e-05	0.000354	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADH1B—alcohol dependence	3.77e-05	0.000351	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.74e-05	0.000349	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADH7—alcohol dependence	3.67e-05	0.000342	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GGT2—alcohol dependence	3.52e-05	0.000328	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MAOB—alcohol dependence	3.42e-05	0.000319	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADH4—alcohol dependence	3.33e-05	0.000311	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GOT2—alcohol dependence	3.27e-05	0.000305	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADH1B—alcohol dependence	3.22e-05	0.0003	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MAOB—alcohol dependence	3.15e-05	0.000294	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MAOB—alcohol dependence	3.12e-05	0.000291	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP2E1—alcohol dependence	3.08e-05	0.000287	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALDH2—alcohol dependence	2.91e-05	0.000271	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADH7—alcohol dependence	2.83e-05	0.000264	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GOT1—alcohol dependence	2.83e-05	0.000264	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GGT1—alcohol dependence	2.83e-05	0.000264	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.8e-05	0.000261	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GGT2—alcohol dependence	2.72e-05	0.000253	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALDH2—alcohol dependence	2.68e-05	0.00025	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MAOB—alcohol dependence	2.67e-05	0.000249	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALDH2—alcohol dependence	2.65e-05	0.000247	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.55e-05	0.000238	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MAOA—alcohol dependence	2.53e-05	0.000236	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.48e-05	0.000232	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GOT2—alcohol dependence	2.47e-05	0.000231	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2E1—alcohol dependence	2.33e-05	0.000217	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GOT2—alcohol dependence	2.28e-05	0.000212	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALDH2—alcohol dependence	2.27e-05	0.000211	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GOT2—alcohol dependence	2.26e-05	0.00021	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.18e-05	0.000203	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2E1—alcohol dependence	2.14e-05	0.0002	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GOT1—alcohol dependence	2.14e-05	0.000199	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GGT1—alcohol dependence	2.14e-05	0.000199	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2E1—alcohol dependence	2.12e-05	0.000198	CbGpPWpGaD
Efavirenz—CYP2B6—adrenal cortex—alcohol dependence	2.1e-05	0.0386	CbGeAlD
Efavirenz—CYP3A4—Metabolism—MAOB—alcohol dependence	2.06e-05	0.000192	CbGpPWpGaD
Efavirenz—CYP2C19—digestive system—alcohol dependence	2.03e-05	0.0374	CbGeAlD
Efavirenz—CYP2D6—Metabolism—GOT1—alcohol dependence	1.96e-05	0.000183	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GGT1—alcohol dependence	1.96e-05	0.000183	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GOT1—alcohol dependence	1.95e-05	0.000182	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GGT1—alcohol dependence	1.95e-05	0.000182	CbGpPWpGaD
Efavirenz—CYP2C19—blood—alcohol dependence	1.94e-05	0.0356	CbGeAlD
Efavirenz—CYP1A2—Metabolism—GOT2—alcohol dependence	1.93e-05	0.00018	CbGpPWpGaD
Efavirenz—CYP2B6—cardiovascular system—alcohol dependence	1.92e-05	0.0352	CbGeAlD
Efavirenz—CYP2C19—Metabolism—MAOA—alcohol dependence	1.91e-05	0.000179	CbGpPWpGaD
Efavirenz—CYP2C9—cardiovascular system—alcohol dependence	1.9e-05	0.0349	CbGeAlD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.86e-05	0.000173	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2E1—alcohol dependence	1.81e-05	0.000169	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MAOA—alcohol dependence	1.76e-05	0.000164	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.75e-05	0.000163	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MAOA—alcohol dependence	1.75e-05	0.000163	CbGpPWpGaD
Efavirenz—CYP2D6—brainstem—alcohol dependence	1.75e-05	0.0321	CbGeAlD
Efavirenz—CYP2B6—gonad—alcohol dependence	1.74e-05	0.032	CbGeAlD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.69e-05	0.000158	CbGpPWpGaD
Efavirenz—CYP2D6—forebrain—alcohol dependence	1.68e-05	0.031	CbGeAlD
Efavirenz—CYP2C19—endocrine gland—alcohol dependence	1.68e-05	0.0309	CbGeAlD
Efavirenz—CYP1A2—Metabolism—GOT1—alcohol dependence	1.66e-05	0.000155	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GGT1—alcohol dependence	1.66e-05	0.000155	CbGpPWpGaD
Efavirenz—CYP1A2—digestive system—alcohol dependence	1.66e-05	0.0305	CbGeAlD
Efavirenz—CYP2B6—Metabolism—POMC—alcohol dependence	1.65e-05	0.000154	CbGpPWpGaD
Efavirenz—CYP2B6—digestive system—alcohol dependence	1.59e-05	0.0293	CbGeAlD
Efavirenz—CYP1A2—blood—alcohol dependence	1.58e-05	0.0291	CbGeAlD
Efavirenz—CYP2C9—digestive system—alcohol dependence	1.58e-05	0.029	CbGeAlD
Efavirenz—CYP2B6—blood—alcohol dependence	1.52e-05	0.0279	CbGeAlD
Efavirenz—CYP2C19—liver—alcohol dependence	1.51e-05	0.0278	CbGeAlD
Efavirenz—CYP2C9—blood—alcohol dependence	1.5e-05	0.0276	CbGeAlD
Efavirenz—CYP1A2—Metabolism—MAOA—alcohol dependence	1.49e-05	0.000139	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GOT2—alcohol dependence	1.49e-05	0.000139	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.45e-05	0.000135	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.4e-05	0.00013	CbGpPWpGaD
Efavirenz—CYP1A2—endocrine gland—alcohol dependence	1.37e-05	0.0252	CbGeAlD
Efavirenz—CYP2B6—endocrine gland—alcohol dependence	1.31e-05	0.0242	CbGeAlD
Efavirenz—CYP2C9—endocrine gland—alcohol dependence	1.3e-05	0.0239	CbGeAlD
Efavirenz—CYP3A4—Metabolism—GOT1—alcohol dependence	1.28e-05	0.00012	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GGT1—alcohol dependence	1.28e-05	0.00012	CbGpPWpGaD
Efavirenz—CYP2B6—testis—alcohol dependence	1.25e-05	0.0231	CbGeAlD
Efavirenz—CYP2C19—Metabolism—POMC—alcohol dependence	1.25e-05	0.000116	CbGpPWpGaD
Efavirenz—CYP1A2—liver—alcohol dependence	1.24e-05	0.0227	CbGeAlD
Efavirenz—CYP2B6—nervous system—alcohol dependence	1.23e-05	0.0226	CbGeAlD
Efavirenz—CYP3A4—digestive system—alcohol dependence	1.2e-05	0.0221	CbGeAlD
Efavirenz—CYP2B6—liver—alcohol dependence	1.19e-05	0.0218	CbGeAlD
Efavirenz—CYP2B6—central nervous system—alcohol dependence	1.18e-05	0.0218	CbGeAlD
Efavirenz—CYP2D6—digestive system—alcohol dependence	1.18e-05	0.0217	CbGeAlD
Efavirenz—CYP2C9—liver—alcohol dependence	1.17e-05	0.0216	CbGeAlD
Efavirenz—CYP3A4—Metabolism—MAOA—alcohol dependence	1.15e-05	0.000107	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—POMC—alcohol dependence	1.15e-05	0.000107	CbGpPWpGaD
Efavirenz—CYP3A4—blood—alcohol dependence	1.14e-05	0.021	CbGeAlD
Efavirenz—CYP2C9—Metabolism—POMC—alcohol dependence	1.14e-05	0.000106	CbGpPWpGaD
Efavirenz—CYP2D6—blood—alcohol dependence	1.13e-05	0.0207	CbGeAlD
Efavirenz—CYP2B6—Metabolism—EP300—alcohol dependence	1.09e-05	0.000102	CbGpPWpGaD
Efavirenz—CYP3A4—endocrine gland—alcohol dependence	9.93e-06	0.0183	CbGeAlD
Efavirenz—CYP2D6—endocrine gland—alcohol dependence	9.77e-06	0.018	CbGeAlD
Efavirenz—CYP1A2—Metabolism—POMC—alcohol dependence	9.71e-06	9.06e-05	CbGpPWpGaD
Efavirenz—CYP2B6—brain—alcohol dependence	9.41e-06	0.0173	CbGeAlD
Efavirenz—CYP2D6—testis—alcohol dependence	9.32e-06	0.0171	CbGeAlD
Efavirenz—CYP3A4—nervous system—alcohol dependence	9.29e-06	0.0171	CbGeAlD
Efavirenz—CYP2D6—nervous system—alcohol dependence	9.14e-06	0.0168	CbGeAlD
Efavirenz—CYP3A4—liver—alcohol dependence	8.95e-06	0.0165	CbGeAlD
Efavirenz—CYP3A4—central nervous system—alcohol dependence	8.95e-06	0.0164	CbGeAlD
Efavirenz—CYP2D6—liver—alcohol dependence	8.81e-06	0.0162	CbGeAlD
Efavirenz—CYP2D6—central nervous system—alcohol dependence	8.8e-06	0.0162	CbGeAlD
Efavirenz—CYP2D6—cerebellum—alcohol dependence	8.61e-06	0.0158	CbGeAlD
Efavirenz—CYP2C19—Metabolism—EP300—alcohol dependence	8.27e-06	7.71e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—EP300—alcohol dependence	7.6e-06	7.09e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—EP300—alcohol dependence	7.54e-06	7.03e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—POMC—alcohol dependence	7.49e-06	6.99e-05	CbGpPWpGaD
Efavirenz—CYP2D6—brain—alcohol dependence	6.99e-06	0.0129	CbGeAlD
Efavirenz—CYP1A2—Metabolism—EP300—alcohol dependence	6.44e-06	6.01e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—EP300—alcohol dependence	4.97e-06	4.64e-05	CbGpPWpGaD
